Trial
NCT05117736
ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure
UnknownTERMINATEDSAFETYConfidence: HIGH
Sponsor
Montreal Heart Institute
Collaborators
Novartis Pharmaceuticals
Condition
Systemic Right Ventricle
Intervention
Sacubitril / Valsartan Oral Tablet
Why stopped
The trial was prematurely terminated due to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-13